Monopar Therapeutics Correlations

MNPR Stock

USD 45.22 1.21 2.61%

The current 90-days correlation between Monopar Therapeutics and Inhibikase Therapeutics is 0.18 (i.e., Average diversification). The correlation of Monopar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Monopar Therapeutics Correlation With Market

Average diversification

The correlation between Monopar Therapeutics and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Monopar Stock

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monopar Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in Monopar Stock, please use our How to Invest in Monopar Therapeutics guide.

Moving against Monopar Stock

0.5	BCH	Banco De Chile Earnings Call This Week	Pair Corr
0.38	KB	KB Financial Group	Pair Corr
0.34	CGEN	Compugen	Pair Corr
0.52	DIS	Walt Disney	Pair Corr
0.48	TRV	The Travelers Companies	Pair Corr
0.43	IBM	International Business Earnings Call Today	Pair Corr
0.43	T	ATT Inc Earnings Call Today	Pair Corr
0.42	WMT	Walmart	Pair Corr
0.41	AXP	American Express	Pair Corr
0.39	CSCO	Cisco Systems Sell-off Trend	Pair Corr
0.38	MSFT	Microsoft Earnings Call This Week	Pair Corr
0.35	AA	Alcoa Corp	Pair Corr

Related Correlations Analysis

	ANTX	IKT	PMVP	ANEB	IPHA	GRTX	TRVI	MIRM	EVLO
ANTX		0.54	-0.57	-0.65	0.71	0.0	0.35	-0.75	0.0	ANTX
IKT	0.54		-0.28	-0.48	0.5	0.0	0.48	-0.58	0.0	IKT
PMVP	-0.57	-0.28		0.8	-0.79	0.0	0.04	0.73	0.0	PMVP
ANEB	-0.65	-0.48	0.8		-0.82	0.0	-0.23	0.84	0.0	ANEB
IPHA	0.71	0.5	-0.79	-0.82		0.0	0.38	-0.81	0.0	IPHA
GRTX	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	GRTX
TRVI	0.35	0.48	0.04	-0.23	0.38	0.0		-0.26	0.0	TRVI
MIRM	-0.75	-0.58	0.73	0.84	-0.81	0.0	-0.26		0.0	MIRM
EVLO	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		EVLO
	ANTX	IKT	PMVP	ANEB	IPHA	GRTX	TRVI	MIRM	EVLO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MIRM	+ 0.84	ANEB
ANEB	+ 0.8	PMVP
MIRM	+ 0.73	PMVP
IPHA	+ 0.71	ANTX
IKT	+ 0.54	ANTX
IPHA	+ 0.5	IKT

High negative correlations

IPHA	- 0.82	ANEB
MIRM	- 0.81	IPHA
IPHA	- 0.79	PMVP
MIRM	- 0.75	ANTX
ANEB	- 0.65	ANTX
MIRM	- 0.58	IKT

Risk-Adjusted Indicators

There is a big difference between Monopar Stock performing well and Monopar Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Monopar Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ANTX	2.09	(0.25)	0.00	(0.43)	0.00	0.00	3.77	(4.17)	20.22
IKT	3.75	(0.29)	0.00	(0.04)	0.00	0.00	9.50	(7.18)	27.87
PMVP	2.68	0.26	0.05	0.69	2.56	(4.13)	8.41	(5.22)	18.30
ANEB	3.85	1.19	0.27	(5.26)	2.87	(5.25)	10.89	(5.77)	28.71
IPHA	2.23	(0.01)	0.00	0.25	0.00	0.00	5.56	(4.81)	17.85
GRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TRVI	2.68	0.14	0.02	0.43	2.93	(3.32)	5.29	(4.48)	19.80
MIRM	1.58	0.32	0.14	0.58	1.75	(1.87)	3.87	(2.27)	14.67
EVLO	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Monopar Therapeutics Corporate Executives

Elected by the shareholders, the Monopar Therapeutics' board of directors comprises two types of representatives: Monopar Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Monopar. The board's role is to monitor Monopar Therapeutics' management team and ensure that shareholders' interests are well served. Monopar Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Monopar Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Christopher Starr	CoFounder Board	Profile
Quan Vu	Principal CFO	Profile
Kim CPA	Secretary, CFO	Profile
Karthik CFA	Principal CFO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC